Alpine Woods Capital Investors’s Virtus Biotech ETF BBP Stock Holding History

Alpine Woods Capital Investors’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,500	Closed	-$370K	–	262
2019 Q4	$370K	Hold	8,500	–	–	0.07%	201
2019 Q3	$305K	Hold	8,500	–	–	0.06%	212
2019 Q2	$349K	Hold	8,500	–	–	0.07%	213
2019 Q1	$381K	Hold	8,500	–	–	0.08%	197
2018 Q4	$297K	Buy	+8,500	New	+$323K	0.07%	215

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SMG

Smart Money Group Eastland, Texas $390M AUM 21.29% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Alpine Woods Capital Investors's BBP Position: Q1 2020 in Review

Alpine Woods Capital Investors sold out of Virtus Biotech ETF (BBP) in Q1 2020, closing a stake of 8,500 shares — an estimated $370K sold.

Alpine Woods Capital Investors first reported a position in BBP in Q4 2018 and held it in 5 quarters. The position peaked at $381K in Q1 2019. 12 funds tracked by Wall St. Rank hold BBP as of Q1 2020.

Alpine Woods Capital Investors reported no remaining Virtus Biotech ETF position as of Q1 2020 after selling out during the quarter.
Alpine Woods Capital Investors sold 8,500 Virtus Biotech ETF shares in Q1 2020, an estimated $370K.
Alpine Woods Capital Investors first reported a position in Virtus Biotech ETF in Q4 2018 and held it in 5 quarters.
Alpine Woods Capital Investors's Virtus Biotech ETF position peaked at $381K in Q1 2019.
12 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2020.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2020, filed 4 May 2020.